COVID-19, SARS and MERS: are they closely related? N Petrosillo, G Viceconte, O Ergonul, G Ippolito, E Petersen Clinical microbiology and infection 26 (6), 729-734, 2020 | 1427 | 2020 |
Crimean-Congo haemorrhagic fever Ö Ergönül The Lancet infectious diseases 6 (4), 203-214, 2006 | 1418 | 2006 |
Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey H Arslan, OK Azap, O Ergonul, F Timurkaynak J Antimicrob Chemother 56 (5), 914-8, 2005 | 482* | 2005 |
Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy Ö Ergönül, A Çelikbaş, B Dokuzoğuz, Ş Eren, N Baykam, H Esener Clinical infectious diseases 39 (2), 284-287, 2004 | 437 | 2004 |
Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study N Tozun, O Ozdogan, Y Cakaloglu, R Idilman, Z Karasu, U Akarca, ... Clinical Microbiology and Infection 21 (11), 1020-1026, 2015 | 395 | 2015 |
Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited O Ergonul, A Celikbas, N Baykam, S Eren, B Dokuzoguz Clinical microbiology and infection 12 (6), 551-554, 2006 | 303 | 2006 |
Evaluation of serum levels of interleukin (IL)–6, IL-10, and tumor necrosis factor–α in patients with Crimean-Congo hemorrhagic fever O Ergonul, S Tuncbilek, N Baykam, A Celikbas, B Dokuzoguz The Journal of infectious diseases 193 (7), 941-944, 2006 | 290 | 2006 |
Treatment of Crimean-Congo hemorrhagic fever O Ergonul Antiviral research 78 (1), 125-131, 2008 | 266 | 2008 |
Crimean–Congo hemorrhagic fever virus: new outbreaks, new discoveries O Ergonul Current opinion in virology 2 (2), 215-220, 2012 | 258 | 2012 |
Occupational exposure to blood and body fluids among health care workers in Ankara, Turkey A Azap, Ö Ergönül, KO Memikoğlu, A Yeşilkaya, A Altunsoy, GY Bozkurt, ... American journal of infection control 33 (1), 48-52, 2005 | 250 | 2005 |
Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness HC Maltezou, L Andonova, R Andraghetti, M Bouloy, O Ergonul, ... Eurosurveillance 15 (10), 19504, 2010 | 248 | 2010 |
Neurobrucellosis: clinical and diagnostic features T Guven, K Ugurlu, O Ergonul, AK Celikbas, SE Gok, S Comoglu, ... Clinical Infectious Diseases 56 (10), 1407-1412, 2013 | 228 | 2013 |
A multinational Delphi consensus to end the COVID-19 public health threat JV Lazarus, D Romeno, CJ Kopka, SAK Karim, LJ Abu-Raddad, ... Nature 611 (7935), 332-345, 2022 | 188 | 2022 |
Clinical and pathologic features of Crimean-Congo hemorrhagic fever O Ergonul Crimean-Congo Hemorrhagic Fever, 207-220, 2007 | 175 | 2007 |
ESCMID COVID-19 living guidelines: drug treatment and clinical management M Bartoletti, O Azap, A Barac, L Bussini, O Ergonul, R Krause, ... Clinical Microbiology and Infection 28 (2), 222-238, 2022 | 162 | 2022 |
A nationwide prevalence study and risk factors for hepatitis A, B, C and D infections in Turkey N Tozun, OC Ozdogan, Y Cakaloglu, R Idilman, Z Karasu, US Akarca, ... Hepatology 52 (4), 697A-697A, 2010 | 134 | 2010 |
The first clinical case due to AP92 like strain of Crimean-Congo hemorrhagic fever virus and a field survey K Midilli, A Gargılı, O Ergonul, M Elevli, S Ergin, N Turan, G Şengöz, ... BMC infectious diseases 9, 1-7, 2009 | 134 | 2009 |
Widal test in diagnosis of typhoid fever in Turkey A Willke, O Ergonul, B Bayar Clinical and Vaccine Immunology 9 (4), 938-941, 2002 | 133 | 2002 |
Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality B Dokuzoguz, AK Celikbas, ŞE Gök, N Baykam, MN Eroglu, Ö Ergönül Clinical infectious diseases 57 (9), 1270-1274, 2013 | 131 | 2013 |
Modeling the spatial distribution of Crimean-Congo hemorrhagic fever outbreaks in Turkey A Estrada-Pena, Z Zatansever, A Gargili, M Aktas, R Uzun, O Ergonul, ... Vector-Borne and Zoonotic Diseases 7 (4), 667-678, 2007 | 128 | 2007 |